Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Plasmodium falciparum | chloroquine resistance transporter | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0597 | 0.0597 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0023 | 0.0738 | 0.5 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0019 | 0.0524 | 0.5776 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0738 | 0.0738 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0026 | 0.0907 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0023 | 0.0738 | 0.9577 |
Plasmodium falciparum | conserved Plasmodium membrane protein, unknown function | 0.0058 | 0.2627 | 0.2436 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0026 | 0.0907 | 0.0515 |
Toxoplasma gondii | transmembrane protein | 0.0157 | 0.7967 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0019 | 0.0524 | 0.68 |
Onchocerca volvulus | 0.0023 | 0.0738 | 0.0226 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.003 | 0.1112 | 0.1112 |
Mycobacterium ulcerans | hypothetical protein | 0.0023 | 0.0738 | 0.5 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0026 | 0.0907 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0077 | 0.3639 | 0.3639 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0023 | 0.0738 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0023 | 0.0738 | 0.0738 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0524 | 0.0524 |
Brugia malayi | beta-lactamase family protein | 0.0023 | 0.0738 | 0.0738 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.1112 | 0.1112 |
Toxoplasma gondii | hypothetical protein | 0.0058 | 0.2627 | 0.2825 |
Entamoeba histolytica | Flap nuclease, putative | 0.0026 | 0.0907 | 0.5 |
Plasmodium falciparum | chloroquine resistance transporter | 0.0157 | 0.7967 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0023 | 0.0738 | 0.8135 |
Plasmodium vivax | chloroquine resistance transporter, putative | 0.0157 | 0.7967 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0738 | 0.0738 |
Onchocerca volvulus | 0.0153 | 0.7727 | 0.7601 | |
Mycobacterium ulcerans | lipase LipD | 0.0023 | 0.0738 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0148 | 0.7488 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.0023 | 0.0738 | 0.0738 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0134 | 0.6726 | 0.6726 |
Echinococcus granulosus | flap endonuclease 1 | 0.0026 | 0.0907 | 1 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0026 | 0.0907 | 0.0242 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0738 | 0.0738 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0023 | 0.0738 | 0.0738 |
Mycobacterium ulcerans | beta-lactamase | 0.0023 | 0.0738 | 0.5 |
Brugia malayi | beta-lactamase | 0.0023 | 0.0738 | 0.0738 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0019 | 0.0524 | 0.5776 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.003 | 0.1112 | 0.1112 |
Brugia malayi | Pre-SET motif family protein | 0.0019 | 0.0524 | 0.0524 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0026 | 0.0907 | 0.0907 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0019 | 0.0524 | 0.5776 |
Schistosoma mansoni | hypothetical protein | 0.0021 | 0.0597 | 0.7748 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0738 | 0.0738 |
Mycobacterium leprae | conserved hypothetical protein | 0.0023 | 0.0738 | 0.5 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0019 | 0.0486 | 0.5355 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0026 | 0.0907 | 0.0515 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0023 | 0.0738 | 0.0738 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0019 | 0.0524 | 0.68 |
Onchocerca volvulus | 0.0023 | 0.0738 | 0.0226 | |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0019 | 0.0524 | 0.68 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.0907 | 0.0896 |
Brugia malayi | Pre-SET motif family protein | 0.0134 | 0.6726 | 0.6726 |
Trichomonas vaginalis | set domain proteins, putative | 0.0153 | 0.7727 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.003 | 0.1112 | 0.1112 |
Mycobacterium leprae | Probable lipase LipE | 0.0023 | 0.0738 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0738 | 0.0738 |
Loa Loa (eye worm) | hypothetical protein | 0.0195 | 1 | 1 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.0907 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0058 | 0.2627 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0021 | 0.0597 | 0.0597 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0058 | 0.2627 | 0.2702 |
Brugia malayi | Flap endonuclease-1 | 0.0026 | 0.0907 | 0.0907 |
Schistosoma mansoni | flap endonuclease-1 | 0.0024 | 0.0771 | 1 |
Onchocerca volvulus | 0.0195 | 1 | 1 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0058 | 0.2627 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0738 | 0.0738 |
Toxoplasma gondii | ABC1 family protein | 0.0023 | 0.0738 | 0.0288 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0077 | 0.3639 | 0.3639 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0026 | 0.0907 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0023 | 0.0738 | 0.9577 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0023 | 0.0738 | 0.8135 |
Brugia malayi | MH2 domain containing protein | 0.0077 | 0.3639 | 0.3639 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0019 | 0.0524 | 0.68 |
Onchocerca volvulus | 0.0023 | 0.0738 | 0.0226 | |
Plasmodium vivax | hypothetical protein, conserved | 0.0023 | 0.0738 | 0.0288 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 19 nM | Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation incubated for 48 hrs prior to [3H]hypoxanthine addition measured after 48 hrs by liquid scintillation counting | ChEMBL. | 22783984 |
IC50 (binding) | = 10.5 uM | Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake measured from 1 to 2 hrs | ChEMBL. | 22783984 |
MSD (functional) | = 30 day | Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in mouse assessed as mean survival days at 30 mg/kg, po administered at 6,24,48 and 72 hrs post-infection (Rvb = 6 to 7 days) | ChEMBL. | 22783984 |
Ratio IC50 (functional) | = 1.2 | Resistance ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum NF54 | ChEMBL. | 22783984 |
Ratio IC50 (functional) | = 1.4 | Resistance ratio of IC50 for chloroquine-resistant Plasmodium falciparum W2 to IC50 for chloroquine-sensitive Plasmodium falciparum D10 | ChEMBL. | 22783984 |
TC50 (ADMET) | < 4 uM | Cytotoxicity against human HepG2 cells after 24 hrs by neutral red dye uptake assay | ChEMBL. | 22783984 |
TC50 (ADMET) | = 16 uM | Cytotoxicity against mouse NIH3T3 cells after 24 hrs by neutral red dye uptake assay | ChEMBL. | 22783984 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 22783984 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.